Takara Bio Inc. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
2,185
2,481
2,905
2,805
3,361
4,823
Depreciation, Depletion & Amortization
1,467
1,672
2,067
2,049
3,217
3,375
Other Funds
17
41
-
-
-
295
Funds from Operations
2,934
3,486
3,912
4,028
5,936
7,906
Changes in Working Capital
683
72
891
444
2,001
2,123
Net Operating Cash Flow
2,251
3,558
3,021
3,584
3,935
5,783
Capital Expenditures
5,713
4,891
2,374
1,517
1,592
Sale of Fixed Assets & Businesses
-
-
-
-
465
Purchase/Sale of Investments
8,898
2,000
1,803
15,269
1,523
Net Investing Cash Flow
14,480
3,168
4,177
13,493
14,755
Cash Dividends Paid - Total
123
143
180
216
480
Issuance/Reduction of Debt, Net
14
129
41
62
723
Net Financing Cash Flow
11,281
231
221
280
1,205
Net Change in Cash
107
640
1,502
16,631
12,148
Free Cash Flow
3,462
1,333
647
2,067
2,343
Net Assets from Acquisitions
-
276
-
-
12,396
Other Sources
131
-
-
-
291
Change in Capital Stock
11,401
-
-
-
-
Exchange Rate Effect
841
481
125
166
123
Other Uses
-
1
-
257
-

About Takara Bio

View Profile
Address
7-4-38 Nojihigashi
Kusatsu Shiga 525
Japan
Employees -
Website http://www.takara-bio.co.jp
Updated 07/08/2019
Takara Bio, Inc. is engaged in the development and marketing of genetic engineering technologies. It operates through the following business segments: Genetic Engineering Research, AgriBio, and Gene Medicine. The Genetic Engineering Research segment offers research reagents, scientific instruments, and contract research services that are essential for biotechnology research.